Yaron Werber
Stock Analyst at TD Cowen
(2.50)
# 3,313
Out of 5,182 analysts
42
Total ratings
48.39%
Success rate
2.83%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yaron Werber
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BNTX BioNTech SE | Maintains: Hold | $116 → $94 | $102.92 | -8.67% | 6 | Mar 11, 2026 | |
| LEGN Legend Biotech | Downgrades: Hold | $62 → $21 | $21.17 | -0.80% | 3 | Jan 22, 2026 | |
| VOR Vor Biopharma | Initiates: Buy | n/a | $16.59 | - | 1 | Dec 17, 2025 | |
| RARE Ultragenyx Pharmaceutical | Maintains: Buy | $86 → $75 | $24.81 | +202.30% | 3 | Nov 5, 2025 | |
| EXEL Exelixis | Maintains: Buy | $44 → $51 | $44.89 | +13.61% | 3 | Nov 5, 2025 | |
| ARGX argenx SE | Maintains: Buy | $800 → $1,146 | $849.04 | +34.98% | 4 | Oct 31, 2025 | |
| IONS Ionis Pharmaceuticals | Maintains: Buy | $59 → $99 | $75.71 | +30.76% | 2 | Oct 30, 2025 | |
| ALEC Alector | Downgrades: Hold | n/a | $2.57 | - | 1 | Oct 22, 2025 | |
| ONC BeOne Medicines AG | Reiterates: Buy | $334 | $323.87 | +3.13% | 1 | Apr 24, 2025 | |
| FBRX Forte Biosciences | Initiates: Buy | n/a | $33.92 | - | 1 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | n/a | $93.26 | - | 1 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | n/a | $26.13 | - | 1 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $160 → $153 | $244.48 | -37.42% | 5 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | n/a | $9.99 | - | 1 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $37.27 | - | 1 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $1.02 | - | 1 | Mar 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $5.56 | - | 2 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $34.55 | - | 1 | Dec 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $8.94 | - | 2 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $38 | $28.55 | +33.10% | 1 | May 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $29.83 | - | 1 | Oct 26, 2021 |
BioNTech SE
Mar 11, 2026
Maintains: Hold
Price Target: $116 → $94
Current: $102.92
Upside: -8.67%
Legend Biotech
Jan 22, 2026
Downgrades: Hold
Price Target: $62 → $21
Current: $21.17
Upside: -0.80%
Vor Biopharma
Dec 17, 2025
Initiates: Buy
Price Target: n/a
Current: $16.59
Upside: -
Ultragenyx Pharmaceutical
Nov 5, 2025
Maintains: Buy
Price Target: $86 → $75
Current: $24.81
Upside: +202.30%
Exelixis
Nov 5, 2025
Maintains: Buy
Price Target: $44 → $51
Current: $44.89
Upside: +13.61%
argenx SE
Oct 31, 2025
Maintains: Buy
Price Target: $800 → $1,146
Current: $849.04
Upside: +34.98%
Ionis Pharmaceuticals
Oct 30, 2025
Maintains: Buy
Price Target: $59 → $99
Current: $75.71
Upside: +30.76%
Alector
Oct 22, 2025
Downgrades: Hold
Price Target: n/a
Current: $2.57
Upside: -
BeOne Medicines AG
Apr 24, 2025
Reiterates: Buy
Price Target: $334
Current: $323.87
Upside: +3.13%
Forte Biosciences
Jan 21, 2025
Initiates: Buy
Price Target: n/a
Current: $33.92
Upside: -
Dec 20, 2024
Initiates: Buy
Price Target: n/a
Current: $93.26
Upside: -
Nov 19, 2024
Initiates: Buy
Price Target: n/a
Current: $26.13
Upside: -
Nov 15, 2024
Maintains: Buy
Price Target: $160 → $153
Current: $244.48
Upside: -37.42%
Nov 5, 2024
Initiates: Buy
Price Target: n/a
Current: $9.99
Upside: -
Mar 26, 2024
Upgrades: Buy
Price Target: n/a
Current: $37.27
Upside: -
Mar 18, 2024
Initiates: Outperform
Price Target: n/a
Current: $1.02
Upside: -
Mar 15, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $5.56
Upside: -
Dec 20, 2023
Initiates: Outperform
Price Target: n/a
Current: $34.55
Upside: -
Nov 1, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $8.94
Upside: -
May 2, 2022
Initiates: Market Perform
Price Target: $38
Current: $28.55
Upside: +33.10%
Oct 26, 2021
Initiates: Outperform
Price Target: n/a
Current: $29.83
Upside: -